![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0015.png)
Page 39
Note:
N o v e m b e r 1 2 - 1 3 , 2 0 1 8 | R o m e , I t a l y
Joint Event on
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
Surgery and Anesthesia 2018 & Euro Gastro Congress 2018
Case Reports in Surgery and Invasive Procedures
|
Volume 2
&
GASTROENTEROLOGY
3
rd
International Conference on
SURGERY AND ANESTHESIA
International Conference on
Fernando Robledo, Case Rep Surg Invasive Proced 2018, Volume 2
INITIAL EXPERIENCE WITH INTRAGASTRIC
BALLOON LEXBAL
®
IN THE TREATMENT
OF PATIENTS WITH MILD TO MODERATE
OBESITY (TYPE I-II)
Fernando Robledo
Maryland-in-Buenos Aires, Argentina
T
o evaluate the effectiveness and response Gastric balloon (Lexbal) in the
treatment of mild to moderate obesity
Methods:
We conducted in one clinic and hospital paroissien an observation-
al, retrospective study. We have compiled the results of 12 follow intragas-
tric balloons (Balon Lexbal ) in obese patients with mild to moderate type
I-II (BMI between 28 and 34.9kg/m2 ) placed in 2012 and 2015 losses have
been achieved over 70% of excess weight . Furthermore, it has been observed
satisfaction of our patients
Measurements:
Descriptive observational study in which the sample is made
up of the 12 patients treated with balloon LEXBAL in our midst. The variables
studied were age, sex, weight, BMI, percentage of weight lost, fill volume, tol-
erance, satisfaction and dietary monitoring by patients
Results:
Over 80% degree of patient satisfaction, 70% decrease in weight
above the average ( over 12 kilos ) better response in those presenting adher-
ence to nutritional treatment and no differences were observed in the volume
of filling the balloon.
Conclusions:
Treatment with intragastric balloon, along with a nutritional
monitoring allows us to re-educate the patient, and change their eating hab-
its. Just for gradual diet, and to adapt each phase as tolerated by the patient,
helps us to improve dietary behavior and facilitates greater weight loss. The
intragastric balloon is a safe, well tolerated, with few adverse effects and rel-
atively simple in the hands accustomed to endoscopic practice. We believe it
can be considered an effective adjunctive therapy in selected cases of mild /
moderate obesity.
Fernando Robledo is currently working at Maryland in
Buenos Aires, Argentina.
frobledo@intramed.netBIOGRAPHY